Last reviewed · How we verify
Physician's Choice SOC — Competitive Intelligence Brief
phase 3
X-ray activated photodynamic therapy agent
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Physician's Choice SOC (Physician's Choice SOC) — Rakuten Medical, Inc.. Physician's Choice SOC is an X-ray activated photodynamic therapy agent that generates reactive oxygen species upon X-ray irradiation to destroy cancer cells.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Physician's Choice SOC TARGET | Physician's Choice SOC | Rakuten Medical, Inc. | phase 3 | X-ray activated photodynamic therapy agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (X-ray activated photodynamic therapy agent class)
- Rakuten Medical, Inc. · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Physician's Choice SOC CI watch — RSS
- Physician's Choice SOC CI watch — Atom
- Physician's Choice SOC CI watch — JSON
- Physician's Choice SOC alone — RSS
- Whole X-ray activated photodynamic therapy agent class — RSS
Cite this brief
Drug Landscape (2026). Physician's Choice SOC — Competitive Intelligence Brief. https://druglandscape.com/ci/physician-s-choice-soc. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab